Want to join the conversation?
$PFE said it will acquire AstraZeneca's development and commercialization rights to its late-stage small molecule anti-infectives business, mainly outside the US. Deal includes rights for Zavicefta, marketed agents Merrem/Meronem and Zinforo, and clinical development assets aztreonam-avibactam and CXL. The deal is expected to close in 4Q16.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!